Survival analysis of untreated patients with non-small-cell lung cancer
… Our results also showed that in the group of untreated patients with lung cancer, following
survival analysis results and survival rates, only two distinctive staging groups could be …
survival analysis results and survival rates, only two distinctive staging groups could be …
[HTML][HTML] Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer
B Győrffy, P Surowiak, J Budczies, A Lánczky - PloS one, 2013 - journals.plos.org
… survival. Here we present the development of an online tool suitable for the real-time
meta-analysis of published lung cancer microarray datasets to identify biomarkers related to survival…
meta-analysis of published lung cancer microarray datasets to identify biomarkers related to survival…
Combined Survival Analysis of Prospective Clinical Trials of Gefitinib for Non–Small Cell Lung Cancer with EGFR Mutations
S Morita, I Okamoto, K Kobayashi, K Yamazaki… - Clinical Cancer …, 2009 - AACR
Purpose: Somatic mutations of the epidermal growth factor receptor (EGFR) gene are associated
with an increased response to gefitinib in patients with non–small cell lung cancer. We …
with an increased response to gefitinib in patients with non–small cell lung cancer. We …
Final overall survival analysis from a study comparing first-line crizotinib versus chemotherapy in ALK-mutation-positive non–small-cell lung cancer
… The final analysis of the PROFILE 1014 study provides a new benchmark for OS in patients
… –small-cell lung cancer and highlights the benefit of crizotinib for prolonging survival in this …
… –small-cell lung cancer and highlights the benefit of crizotinib for prolonging survival in this …
The long-term impact of surgical complications after resection of stage I nonsmall cell lung cancer: a population-based survival analysis
NM Rueth, HM Parsons, EB Habermann… - Annals of …, 2011 - journals.lww.com
… nonsmall cell lung cancer (NSCLC), we sought to determine the long-term survival impact of
… be associated with both operative morbidity and cancer survival, it was our aim to separate …
… be associated with both operative morbidity and cancer survival, it was our aim to separate …
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.
CJ Langer, JC Leighton, RL Comis… - Journal of clinical …, 1995 - ascopubs.org
… and Taxol in advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 13:351, 1994 …
lung cancer cell lines to paclitaxel increases the cytotoxicity. Proc Int Assoc Study Lung Cancer …
lung cancer cell lines to paclitaxel increases the cytotoxicity. Proc Int Assoc Study Lung Cancer …
[HTML][HTML] Survival analysis part I: basic concepts and first analyses
… For the purposes of this series, we will focus on the time to first relapse (including death
from lung cancer). Table 1 gives the time of the earliest 15 and latest five relapses for each …
from lung cancer). Table 1 gives the time of the earliest 15 and latest five relapses for each …
Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter …
C Butts, A Maksymiuk, G Goss, D Soulieres… - Journal of cancer …, 2011 - Springer
… analysis summarized above was March 2004. In this paper, we describe an updated survival
analysis in … We also present the 3-year survival rates in the intent-to-treat population and …
analysis in … We also present the 3-year survival rates in the intent-to-treat population and …
… III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non–small-cell lung cancer: updated survival analysis of JBR-10
CA Butts, K Ding, L Seymour… - Journal of clinical …, 2010 - ascopubs.org
Purpose Adjuvant cisplatin-based chemotherapy (ACT) is now an accepted standard for
completely resected stage II and III A non–small-cell lung cancer (NSCLC). Long-term follow-up …
completely resected stage II and III A non–small-cell lung cancer (NSCLC). Long-term follow-up …
[HTML][HTML] Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial
DE Ediebah, C Coens, E Zikos, C Quinten… - … journal of cancer, 2014 - nature.com
… Lung cancer is the most common cancer worldwide, in terms of both incidence and … to lung
cancer. The highest rates are in Europe and North America (Ferlay et al, 2010). Lung cancer …
cancer. The highest rates are in Europe and North America (Ferlay et al, 2010). Lung cancer …
相关搜索
- final overall survival analysis lung cancer
- updated survival analysis lung cancer
- risks analysis lung cancer
- cell lung cancer
- lung cancer resection
- small cell lung cancer egfr mutations
- first line crizotinib lung cancer
- paclitaxel cisplatin lung cancer
- lung cancer patients
- blp25 liposome vaccine lung cancer
- completely resected stage lung cancer
- adjuvant chemotherapy lung cancer
- survival analysis software lung cancer
- gene expression signatures lung cancer survival
- non-small cell lung cancer unresectable stage
- small cell lung cancer equal survival